
    
      OBJECTIVES:

        -  To evaluate the impact of stellate ganglion blockade on hot flash scores.

        -  To evaluate the toxicity of stellate ganglion blockade.

      OUTLINE: Patients undergo fluoroscopic-guided stellate ganglion blockade using bupivacaine
      hydrochloride in week 1.

      Patients complete a hot flash diary daily and a symptom experience diary weekly in weeks 1-7
      and the Profile of Mood States questionnaire in weeks 1 and 7.

      After completion of study treatment, patients are followed at 2 months and then monthly for 1
      year.
    
  